Adults 4 to 14, any sex, with Cognitive Behavioral Therapy or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
7-item Pediatric Anxiety Rating ScalePrimary· Baseline (before treatment), mid-treatment (on average 12 weeks), post-treatment (on average 24 week), 3 month follow up; Post-treatment scores are reported.
Clinician rated child anxiety severity throughout the past week. Each item is scored on a 0 to 5 scale (higher scores correspond to greater severity), yielding a total between 0 and 35.
Group
Value
95% CI
Stepped Care CBT
11.87
± 6.93
Clinical Global Impression-ImprovementPrimary· Mid-treatment (on average 12 weeks), post-treatment (on average 24 week), 3 month follow up; Post-treatment scores are reported.
Clinician rated child psychopathology improvement since initial rating. A single item is scored 0-6 (0 = very much worse; 6= very much improved).
Group
Value
95% CI
Stepped Care CBT
42
Clinical Global Impression-SeveritySecondary· Baseline (before treatment), mid-treatment (on average 12 weeks), post-treatment (on average 24 week), 3 month follow up; Post-treatment scores are reported.
Clinician rated child psychopathology severity rating. A single item is scored 0-6 (0= no illness; 6= extremely severe symptoms).
Group
Value
95% CI
Stepped Care CBT
1.88
± .98
Sponsor's own description
This study implements a parent-led, flexible, individually-tailored cognitive-behavioral intervention for children with ASD and anxiety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other recruiting trials for Cognitive Behavioral Therapy
Currently open trials in the same condition.
NCT07232823 — Brief Culturally Adapted CBT for OCD
· NA
· recruiting
NCT06454695 — Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery
· NA
· recruiting
NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program
· NA
· recruiting
NCT05609916 — CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD
· NA
· recruiting
NCT04761328 — Fear of Recurrence and Stopping Immunotherapy
· NA
· recruiting
Other Baylor College of Medicine trials
Trials by the same sponsor.
NCT07513194 — GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)
· Phase 1
· not yet recruiting
NCT05855824 — Toddler Biomarker of Nutrition Study
· NA
· not yet recruiting
NCT06738628 — Disposable Endoscope Platform in Third Space Endoscopic Procedures
· not yet recruiting
NCT06834997 — Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital
· Phase 2
· withdrawn
NCT07387614 — WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor College of Medicine
Last refreshed: 15 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03720795.